The Chicago Entrepreneur

Dow Jones Newswires: 4D Pharma restates first-half earnings due to accounting change

The London- and U.S.-listed pharmaceutical company said the warrants and units should be recorded as derivative liabilities and not equity instruments under both IFRS and U.S. GAAP accounting standards.

Previous post Futures Movers: Stock futures reverse early losses after Biden, Putin agree ‘in principle’ to summit
Next post Dow Jones Newswires: Sharp Corp. shares fall sharply on plan to acquire display affiliate